Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

2.05
Delayed Data
As of Jul 26
 +0.03 / +1.49%
Today’s Change
1.82
Today|||52-Week Range
11.45
-37.88%
Year-to-Date
No recent news for Cancer Genetics Inc.

Today’s Trading

Previous close2.02
Today’s open2.01
Day’s range2.00 - 2.05
Volume21,722
Average volume (3 months)103,341
Market cap$32.6M
Dividend yield--
Data as of 07/26/2016

Growth & Valuation

Earnings growth (last year)-8.89%
Earnings growth (this year)+35.71%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+76.87%
P/E ratioNM
Price/Sales1.88
Price/Book0.84

Competitors

 Today’s
change
Today’s
% change
TROVUTrovagene Inc0.000.00%
INISInternational Isotop...-0.01-8.57%
ERBERBA Diagnostics Inc-0.02-3.77%
GALTGalectin Therapeutic...+0.00+0.32%
Data as of 07/26/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$18.0M
Annual profit (last year)-$20.2M
Net profit margin-111.88%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
President, Chief Executive Officer &
Director
Panna L. Sharma
Chief Operating Officer &
EVP-Finance
John A. Roberts
Corporate headquarters
Rutherford, New Jersey

Forecasts

Partner Offers

Search for Jobs